Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

I-Sens, Inc. — Predicate Candidate Screening

27 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

122 daysmedian FDA review time
357 days90th percentile
27clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K230625ReliOn Premier BLU Blood Glucose Monitoring SystemI-Sens, Inc.2023-08-101570
K222656LDE4 Lancing DeviceI-Sens, Inc.2022-11-23820
K201394CareSens N Feliz Blood Glucose Monitoring System, CareSens NI-Sens, Inc.2021-10-054960
K201551KetoSens BT Blood B-Ketone Monitoring SystemI-Sens, Inc.2020-09-09920
K192859CareSens S Clear BT Blood Glucose Monitoring SystemI-Sens, Inc.2020-01-241120
K193590CareSens S Fit BT Blood Glucose Monitoring SystemI-Sens, Inc.2020-01-17250
K192220ReliOn Premier Classic Blood Glucose Monitoring SystemI-Sens, Inc.2019-12-131200
K181273GLUCOCARD Shine Connex Blood Glucose Monitoring System, GLUCI-Sens, Inc.2018-11-011710
K180866CareSens S Fit Blood Glucose Monitoring SystemI-Sens, Inc.2018-08-311510
K170463KetoSens Blood B-Ketone Monitoring System, KetoSens Multi BlI-Sens, Inc.2018-04-134220
K171480NoCoding1 Plus Blood Glucose Monitoring System, VeraSens BloI-Sens, Inc.2017-12-132080
K170614CareSens N Premier Blood Glucose Monitoring System, CareSensI-Sens, Inc.2017-10-192320
K160742NoCoding1 Plus Blood Glucose Monitoring SystemI-Sens, Inc.2016-12-162740
K151164Assure Prism multi Blood Glucose Monitoring SystemI-Sens, Inc.2015-08-07980
K133346SMARTLOG DIABETES MANAGEMENT SOFTWAREI-Sens, Inc.2013-12-19500
K132288CARESENS N VOICE MULTI BLOOD GLUCOSE MONITORING SYSTEM, CAREI-Sens, Inc.2013-11-221220
K130696CARESENS N LINK BLOOD GLUCOSE MONITORING SYSTEM; CARESENS N I-Sens, Inc.2013-08-211600
K131419ACURA PLUS MULTI BLOOD GLUCOSE MONITORING SYSTEMI-Sens, Inc.2013-08-09850
K121654AUTO-CHEK BLOOD GLUCOSE MONITORING SYSTEM, METER, TEST STRIPI-Sens, Inc.2012-09-05920
K121133CARESENS N VOICE BLOOD GLUCOSE MONITORING SYSTEMI-Sens, Inc.2012-07-10880
K120759CARESENS N MINI BLOOD GLUCOSE MONITORING SYSTEM, MINI BLOOD I-Sens, Inc.2012-06-05840
K120351CARESENS N POP BLOOD GLUCOSE MONITORING SYSTEM CARESENS N POI-Sens, Inc.2012-05-03870
K103278ACURA PLUS BLOOD GLUCOSE MONITORING SYSTEM; ACURA PLUS BLOODI-Sens, Inc.2011-10-283570
K103396COOL BLOOD GLUCOSE MONITORING SYSTEM, BLOOD GLUCOSE METER, CI-Sens, Inc.2011-09-273120
K100937PC CARE BLOOD GLUCOSE DATA MANAGEMENT SOFTWAREI-Sens, Inc.2010-12-212600
K083468CARESENS N BLOOD GLUCOSE MONITORING SYSTEM, CARESENS N METERI-Sens, Inc.2009-02-10780
K080923CARESENS BLOOD GLUCOSE MONITORING SYSTEM; CARESENS II METER,I-Sens, Inc.2008-10-171980

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda